IP Library Granted Patent US 8,197,529
Granted Patent B2
US 8,197,529 · App. 12/491,895 · Granted Jun 12, 2012

Removable stent-graft

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,197,529
App. No.
12/491,895
Granted
Jun 12, 2012
Kind
B2
Abstract

A removable device such as a stent-graft, intended for applications where it may be desirable to remove the device at some time following implantation. The stent-graft of the present invention includes a helically-wound stent component provided with a covering of graft material. It is removable by gripping an end of the helically-wound stent component with a retrieval device and applying tension to the stent component in the direction in which it is intended to be withdrawn from the site of implantation. The use of such a retrieval device allows the stent-graft to be removed remotely, such as via a catheter inserted into the body at a different location from the implantation site. The design of the stent-graft is such that the stent component is extended axially while the adjacent portion of the graft separates between windings of the stent component. The axial extension of the stent component, with portions of the graft still joined to the stent component, allows the device to be “unraveled” (or “unwound”) and removed through a catheter of diameter adequately small to be inserted into the body cavity that contained the stent-graft. It is removed atraumatically, without incurring significant trauma to the body conduit in which it had been deployed.

Claims (22)

1. An endoprosthesis comprising:

a stent component having opposing ends and further having a reduced delivery profile and an enlarged deployed profile;

said stent component comprising a wire formed into a helical winding having space between adjacent elements of the helical winding, wherein the helical winding provides a tubular form to the stent component and wherein the helical winding includes at least one apex located between the opposing ends of the stent component;

a graft material attached to the stent component covering the space between each adjacent element of the helical winding, wherein the graft material provides a continuous luminal surface between the opposing ends of the stent component; and

wherein at least one of said apices located between the opposing ends of the stent component is raised to protrude outwardly from said tubular form and wherein the resulting raised apex is covered by said graft material.

2. The endoprosthesis of claim 1 wherein following deployment, the endoprosthesis is adapted to be cohesively disassembled to allow for its remote removal from a patient.

3. The endoprosthesis of claim 1 wherein at least a portion of the helical winding has a serpentine form with alternating opposing apices.

4. The endoprosthesis of claim 3 wherein following deployment, the endoprosthesis is adapted to be cohesively disassembled to allow for its remote removal from a patient.

5. The endoprosthesis of claim 1 wherein said graft material is impermeable to body fluids.

6. The endoprosthesis of claim 1 wherein said graft material is ePTFE.

7. The endoprosthesis of claim 6 wherein said graft material is ePTFE provided with a coating of FEP.

8. An endoprosthesis comprising:

a stent component having opposing ends and further having a reduced delivery profile and an enlarged deployed profile;

said stent component comprising helically arranged structural elements and space between adjacent structural elements, wherein the structural elements provide a tubular form to the stent component and wherein the structural elements include at least one apex located between the opposing ends of the stent component;

a graft material attached to the stent component covering the space between each adjacent structural element, wherein the graft material provides a continuous luminal surface between the opposing ends of the stent component; and

wherein at least one of said apices located between the opposing ends of the stent component is raised to protrude outwardly from said tubular form and wherein the resulting raised apex is covered by said graft material whereby encapsulation of the raised apex by living tissue is prevented.

9. The endoprosthesis of claim 8 wherein following deployment, the endoprosthesis is adapted to be cohesively disassembled to allow for its remote removal from a patient.

10. The endoprosthesis of claim 8 wherein at least a portion of the stent component has a serpentine form with alternating opposing apices.

11. The endoprosthesis of claim 10 wherein following deployment, the endoprosthesis is adapted to be cohesively disassembled to allow for its remote removal from a patient.

12. The endoprosthesis of claim 8 wherein said graft material is impermeable to body fluids.

13. The endoprosthesis of claim 8 wherein said graft material is ePTFE.

14. The endoprosthesis of claim 13 wherein said graft material is ePTFE provided with a coating of FEP.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2012
From: GORE ENTERPRISE HOLDINGS, INC.
To: W. L. GORE & ASSOCIATES, INC.
Reel/Frame 027906/0508 →